Evelo Biosciences, Inc. Insider Trading for May 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Evelo Biosciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Evelo Biosciences, Inc. for May 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 4,643,963 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 18,611,110 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 8,333,000 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 5,416,667 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 10,102,055 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 12,536,945 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 16.00 | 281,250 | 4,500,000 | 18,233,403 | 18 M to 18.2 M (+1.57 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | C | 0.00 | 14,622,143 | 0 | 17,952,153 | 3.3 M to 18 M (+439.10 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 4,643,963 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 18,611,110 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 8,333,000 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 5,416,667 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 10,102,055 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 12,536,945 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | P | 16.00 | 281,250 | 4,500,000 | 18,233,403 | 18 M to 18.2 M (+1.57 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 14,622,143 | 0 | 17,952,153 | 3.3 M to 18 M (+439.10 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 4,643,963 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 18,611,110 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 8,333,000 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 5,416,667 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 10,102,055 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Option Exercise | C | 0.00 | 12,536,945 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | P | 16.00 | 281,250 | 4,500,000 | 18,233,403 | 18 M to 18.2 M (+1.57 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund IV Gene ... | 10% Owner | Buy | C | 0.00 | 14,622,143 | 0 | 17,952,153 | 3.3 M to 18 M (+439.10 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 4,643,963 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 18,611,110 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 8,333,000 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 5,416,667 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 10,102,055 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Option Exercise | C | 0.00 | 12,536,945 | 0 | 0 | |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | P | 16.00 | 281,250 | 4,500,000 | 18,233,403 | 18 M to 18.2 M (+1.57 %) |
May 15 2018 | EVLO | Evelo Biosciences, ... | Flagship Ventures Fund V Gener ... | 10% Owner | Buy | C | 0.00 | 14,622,143 | 0 | 17,952,153 | 3.3 M to 18 M (+439.10 %) |
May 10 2018 | EVLO | Evelo Biosciences, ... | Poole Jonathan | CFO | Option Exercise | A | 16.00 | 71,497 | 1,143,952 | 71,497 | |
May 10 2018 | EVLO | Evelo Biosciences, ... | GILL SIMBA | President & CEO | Option Exercise | A | 16.00 | 145,869 | 2,333,904 | 145,869 | |
May 10 2018 | EVLO | Evelo Biosciences, ... | McHale Duncan | Chief Medical Offic ... | Option Exercise | A | 16.00 | 79,052 | 1,264,832 | 79,052 | |
May 10 2018 | EVLO | Evelo Biosciences, ... | Bodmer Mark | See Remarks | Option Exercise | A | 16.00 | 55,437 | 886,992 | 55,437 | |
May 10 2018 | EVLO | Evelo Biosciences, ... | Simonian Nancy A | Director | Option Exercise | A | 16.00 | 31,380 | 502,080 | 31,380 |